Incidence of community onset MRSA in Australia: least reported where it is Most prevalent

Abstract

BackgroundThis is the first review of literature and synthesis of data on community onset methicillin resistant Staphylococcus aureus (CO-MRSA) infections in Australia. Incidence of CO-MRSA varies considerably in Australia, depending on geographic and demographic factors.MethodsData for the rates of MRSA infections were collected from articles identified using PubMed, Scopus, the grey literature and data from State and Federal Government Surveillance Systems. We synthesized data and developed a framework for how data was selected, collated, linked, organized and interpreted.ResultsThe results of our literature search demonstrates considerable gaps in the reporting of CO-MRSA in Australia. Consequently, total incidences were under reported; however the available data suggests the incidence varied between 44 (Tasmania) and 388 (southern Northern Territory) cases per 100,000 person years. Hospitalised cases of CO-MRSA varied between 3.8 (regional Victoria) and 329 (southern Northern Territory). Taking the median percentage of infections by site for all regions available, skin and soft tissue infections (SSTIs) consisted of 56% of hospitalized CO-MRSA, compared with bacteremias, which represented 14%. No region had a complete data set of CO-MRSA infections treated in out-patient settings and so incidences were underestimates. Nevertheless, estimates of the incidence of CO-MRSA treated outside hospitals varied between 11.3 (Melbourne) and 285 (Northern Territory) per 100,000 person-years. These infections were chiefly SSTIs, although urinary tract infections were also noted.Incidences of CO-MRSA blood-stream infections and outpatient skin and soft tissue infections have been increasing with time, except in Tasmania. CO-MRSA is observed to affect people living in remote areas and areas of socioeconomic disadvantage disproportionately.ConclusionsWe generated the first estimates of the incidence of CO-MRSA infections in Australia and identified stark regional differences in the nature and frequency of infections. Critically, we demonstrate that there has been a lack of consistency in reporting CO-MRSA and a general dearth of data. The only government in Australia that requires reporting of CO-MRSA is the Tasmanian, where the infection was least prevalent. Some regions of Australia have very high incidences of CO-MRSA. To improve surveillance and inform effective interventions, we recommend a standardized national reporting system in Australia that reports infections at a range of infection sites, has broad geographic coverage and consistent use of terminology. We have identified limitations in the available data that hinder understanding the prevalence of CO-MRSA.Electronic supplementary materialThe online version of this article (10.1186/s13756-019-0485-7) contains supplementary material, which is available to authorized users.

Antimicrobial stewardship in rural and remote primary health care: a narrative review

“…As the distance from major cities increases, death rates increase, access to health services decline and rates of preventable hospitalisations for chronic diseases markedly rise [ 17 – 19 ]. Recent publications have identified the significant burden of infections and antimicrobial use in remote Australian committees and an upward trend of AMR [ 11 , 20 , 21 ].…”

Longitudinal whole-genome based comparison of carriage and infection associated Staphylococcus aureus in northern Australian dialysis clinics

“…In the current study, 12% of the nasal isolates were MRSA, which equates to 1.5% of the nasal swabs yielding MRSA. While there is extensive reporting that the Australian Northern Territory population has a disproportionate burden of disease caused by MRSA [14,15,27,28], little is known regarding the extent that this this is driven by MRSA carriage. One Indigenous community-based study from more than a decade ago did show significant MRSA carriage [29].…”

“…An extraordinarily high burden of end stage kidney disease is experienced in northern Australia, which disproportionately affects Aboriginal peoples [12,13]. Within this region, there is also an unusually high prevalence of S. aureus infection, much of which is associated with known community acquired strains [14,15].…”

Antimicrobial Resistance Surveillance to Support Decision-Making in a High-Prevalence Region: An Evaluation

“…Northern Australia is a large geographical region (comprising half of the Australian landmass) which is home to only 5.2% of the total population (1.3 million), and 30% of the total Aboriginal and Torres Strait Islander population (6). Despite the sparse population, it is a region of high AMR prevalence (7) combined with a complex interplay of socio-economic factors that are likely contributing to the disease burden in this setting (8). National progress to track and respond to AMR systematically in regional and rural Australia are insufficient (7,8) and are not timely (9).…”

“…Despite the sparse population, it is a region of high AMR prevalence (7) combined with a complex interplay of socio-economic factors that are likely contributing to the disease burden in this setting (8). National progress to track and respond to AMR systematically in regional and rural Australia are insufficient (7,8) and are not timely (9).…”